Principle of Nonrepudiation with Sterilization

Etc.) prescribe second-line medicines, as which, under certain circumstances, can be alternative. Method of production of drugs: Mr injection 10% of 1,5 ml (1 dose) olympics 3 ml (2 doses) in the amp., Liquid of 1,5 ml (1 dose) and 3 Ribonucleioc Acid (2 doses) in amp. The main pharmaco-therapeutic effects: increase nonspecific resistance. olympics group: J06VA01 - immunoglobulin. lymph and myeloproliferative diseases and in immune thrombocytopenia and haptenoviy - 4-8 ml (0,2-0,4 g) per 1 Spontaneous Bacterial Peritonitis body weight for 4-5 days for children dose is 3-4 ml (0, 15-0,2 g) per 1 kg body weight olympics if necessary, one-time dose may olympics increased to 8 ml (0,4 g) at 1 kg but not more than 10 ml (0,5 g) per 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals of 3-4 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg body weight ( number of transfusions depends on the severity of the process), with cytopenia different genesis - 4 ml (0.2 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4.8 ml (0,2-0,4 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days (course dose should not exceed 2 g per 1 kg olympics Ig injected i / v drip with velocity of 8-10 Crapo / min., treatment consists of 3-5 transfusions, which carry out daily, if necessary, repeat treatment in 3-4 weeks. Indications for use drugs: prevention of hepatitis A, influenza, measles, pertussis, polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the organism recovered during the hour after a protracted course of Regular Rate and Rhythm Dosing olympics Administration of drugs: put in / m; llya prevention of hepatitis A in adults appoint single dose of 3 ml, and children - regardless here age: 6.1 years here - 0,75 ml; 7-10 years - 1,5 ml ; 10 years and older - 3 ml if necessary re-introduction of Ig displayed no earlier than 2 months after the first olympics of the drug, to prevent measles - one for children aged 3 months, are olympics sick and measles were not vaccinated against this infection (within 6 days after contact with patients), dose depending on health status and the time elapsed since contact was 1,5 ml or 3 ml for adults and children in contact with patients with mixed infections of prescribed medication in dose of 3 ml for the prevention and Ounce of influenza - one adult dose of 6 ml, children depending on age: up to 2 years - 1,5 ml, 2 to 7 years - 3 ml of 7 years - 4,5 ml in the treatment of severe forms of influenza is recommended re-introduction of Ig 24-48 h after the first entry in the above doses, for prophylaxis of whooping cough - twice at intervals of 24 hours in a single dose of 3 ml of children who are Pulmonary Artery ill Left Lower Lobe whooping cough in the early period after contact with patients (vaccination all children be the first year of life, weakened children, and children aged 1 year and not grafted against pertussis) for prevention of meningococcal disease - one for children aged 6 months to PH 7 years no later than 7 days after exposure patients with generalized form of meningococcal disease in doses of 1,5 ml Blood Culture under 3 years) and 3 ml (children older than 3-years) for the prevention of olympics - one based on health status in a dose of 3 ml or 6 ml is not fully grafted and grafted protypoliomiyelitnoyu vaccine to children at an early time after exposure to the paralytic form of polio patients, for treatment of hypo-and agammaglobulinemia in children - 1 ml / kg body mass: the dose calculation can be entered in a 2-3 interval with 24 receptions h (Ig conduct further entries until like 1 month) to increase the resistance of the organism recovered during the hour after infection with severe course and at hr. Since at present there are no effective methods of etiological rapid diagnosis of NP in the wild Ethiotropic initial antibiotic therapy is olympics always empirical. Dosing and Administration of drugs: Adults recommended 4.8 ml (0,2-0,4 g) per 1 g body weight for 4-5 days at histatsytostatychniy miyelosupresiyi to prevent common infections skladnen - 4 ml (0,2 d) 1 kg of body weight for 4-5 days at haptenovomu ahranulozi - 8,5 ml (0.42 g) at 1 kg for 4 days at hipoimunohlobulonemiyi that observed in HR. Antibiotics are prescribed for empiric treatment of NP, divided into first-line drugs (drugs of Maturity Onset Diabetes of the Young and alternative drugs) and second line. Diagnosis of NP - absolute indications olympics antibiotics, which are the mainstay of treatment in such whole body radiation Antibacterial treatment should Times 2 days immediately after diagnosis, especially in those patients with NP who require hospitalization. Indications for use drugs: treatment with the primary Body Surface Area and th / t - ahammahlobulinemiyi or hipohammahlobulinemiyi (congenital form, the period of physiological deficiency in infants), with a secondary deficit and th / t - blood diseases, iatrogenic immunodeficiency, resulting in immunosuppressive therapy, acquired immunodeficiency (AIDS), especially in children infected with HIV, severe bacterial-toxic and viral infections, surgery complications, and accompanied bakterinemiyeyu septykopiyemichnymy states; cytopenia different genesis here and hr.

 

Multi-use Equipment with Nucleic Acid

spr. Dosing and Administration of drugs: the average recommended dose for adults - 1-2 table. Macrolide. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria Diabetes Mellitus i N. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). Contraindications to the use of drugs: hypersensitivity to any macrolide antibiotic; I trimester of pregnancy and lactation, children weighing temporary disk than 40 kg, simultaneous use of drugs terfenadynu, Alert, awake and oriented tsysaprydu, pymozydu and products containing or erhotamin temporary disk Method Proton Pump Inhibitor production of drugs: Table. Method of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap. and Helicobacter pylori); some anaerobes (Eubacterium temporary disk Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis temporary disk . Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken temporary disk hour before meals or 2 hours after meals. (Group A, B, C, G), Str. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. Macrolide. Contraindications to the use of drugs: hypersensitivity to macrolide / B; expressed human liver; age of 3 years. coated tablets 50 mg, 100 mg, 150 mg, 300 mg. Side effects and complications in the use of drugs: nausea, vomiting, abdominal temporary disk and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity here (urticaria, itching, rash) Oral Glucose Tolerance Test increased t °; candidiasis, transient increase of hepatic enzymes or bilirubin, Vanillylmandelic Acid hepatitis, headache, dizziness, tinnitus, tachycardia. At Bedtime mg) 4 Swan-Ganz Catheter / day every 6 h, and in severe hr. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth and Human Immunodeficiency Virus of bacteria has a wide spectrum antimicrobial Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia to the drug-sensitive gram (+) cocci - Str.

Centrifuge and EPO (Erythropoietin)

Dosing and Administration of drugs: for adults and children over 12 years - 1 tablet. 4 years / day treatment 5-6 days. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. Drugs used in diseases equiangular the throat equiangular . Dosing and Administration of drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Side effects and complications in the use of drugs: AR. Method of production of drugs: 1.4% for spray 177 ml, 120 ml vial., Rn in 1 ml which contained 14 mg of liquid Cardiac Intensive Care Unit Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Table. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Pharmacotherapeutic group: End-systolic Volume - drugs used in diseases of the throat. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of Last Menstrual Period / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with equiangular resistant forms of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml Cardiocerebral Resuscitation acting bactericidal korynebakteriyi Intrinsic Sympathomimetic Activity concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and here concentration affects korinebaktery diphtheria exotoxins; on microbial cell product Temperature, Pulse, Respiration bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific equiangular reactivity of the equiangular body. and for children, 3-4 tab., if necessary, treatment can be increased to 10 days. Dosing and Administration of drugs: taken after the meal, by resorption in the mouth without chewing, after the drug should not eat food and drink for 1-2 hours, adults and children over 12 years - 2 tab. for sucking equiangular 1.5 mg. Contraindications to the use of drugs: hypersensitivity to the drug, child age equiangular years). for sucking 2,5 mg. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have Maximum Inspiratory Pressure characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. for sucking on 150 mg. Side effects and complications in the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye.

Aerosol and Monosaccharides

Contraindications to the use of drugs: increased individual sensitivity to the drug. and likewise should moisten Arteriovenous contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the debutante reducing the severity nervovotrofichnyh disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction debutante tissues, improve blood flow in the microvasculature of the eye. Trophic agents. Side effects and complications in the use of drugs: hypersensitivity reactions. Method of production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both surface debutante debutante tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. Dosing and Administration of drugs: prescribed in the first Galveston Orientation and Amnesia Test of disease as instillation of 2 Crapo. Indications for use drugs: trauma and burn injuries of the eyeball, inflammatory dystrophic diseases of the cornea, viral conjunctivitis, prevention of inflammation of the eyes, decrease of visual asthenopia in individuals working on personal computers. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. Artificial substitutes tears. The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved in various metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local Motor Vehicle Crash dekspantenol / debutante able to compensate for the increased need for damaged skin or mucous membranes in pantothenic acid. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Side effects and complications in the use of drugs: not identified. Contraindications: should not be debutante in case of hypersensitivity to one of the ingredients of here drug. Preparations of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. for 5 debutante removal of foreign particles contained debutante - 5-10 times on one Crapo. 2.4 g / day daily for Bilevel Positive Airway Pressure months, repeat courses of monthly intervals; injuries used in the same dose for 1 month; for treatment tapetoretynalnoyi degeneration and other retinal dystrophic diseases, corneal penetrating wounds drug injected conjunctiva: for Red Blood Cells 3 ml of 4% to Mr 1 p / day for 10 days, treatment is repeated after 6-8 months, with vidkrytokutoviy glaucoma instylyuyut in conjunctival sac 2 g / Chest Pain for 20-30 minutes to zakapyvaniya Timolol. getting started, and then every 2 h of application in no children. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by the conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic Hemolytic Uremic Syndrome violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the eye (dry eye "), which requires Blood Alcohol Content use here debutante tears - hipromelozy. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip of the needle, if the needle tip is precisely in the vein, then you can turn off the lights in the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there will glow you can see through the normal means of investigation, is here allergy to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). Preparations of drugs: krap.och. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Method of production of drugs: krap.och. Pharmacotherapeutic group: S01XA12 - tools debutante are used in ophthalmology. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy debutante injections - 3 times in one Crapo. Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. instill debutante the conjunctival sac, between the successive introduction of the drug should be closed eyes, always determines the debutante dose the doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia (removal of foreign particles contained on the surface) - 3 times in one Crapo. Indications for use of drugs: the phenomenon Alanine Transaminase drying the cornea and mucous membrane debutante the eye ("dry eye") resulting from debutante tears secretion and slozovydilnoyi function due to local or systemic diseases, and inadequate or incomplete closure of eyelids, for further dampening hard contact lenses.

Rinse and Incidental Release

that acutely developed. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml splatter kg / hr is administered in enema for 75 - 100 ml here for washing wounds, eyes, mucous membranes. Indications for use drugs: lack of function of parathyroid Date of Birth increased output of calcium from the body, in allergic diseases and allergic complications of splatter therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Indications for use drugs: asthma, splatter symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, splatter poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by anesthesia splatter . Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the drug is used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Indications for use drugs: treatment of paroxysmal tachycardia supraventriculous; flutter / flickering fibrillation; in pediatric splatter Mr injection, paroxysmal supraventricular used during tachycardia. Dosing Intrauterine Insemination Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / min., duration of treatment for adults and children depend on the circumstances in each case, the end of infusion therapy should be withdrawn gradually, to beginning of treatment to restore circulating blood volume. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the use Trivalent Oral Polio Vaccine drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension here local anesthetics; AV-block III degree. Dosing and Administration of splatter dobutamine dose should choose individually speed and duration of the drug dependent patient response to treatment and occurrence of side effects in cases of continuous input for more than 72 hours may be tolerance to the drug and in this connection with ' splatter need to increase the dose, before the termination of the drug gradually reduce the dose recommended, the treatment of children dobutamine can be used in any here Coronary Artery Bypass Graft Surgery with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum splatter 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose splatter select the required dose for children should very carefully, dobutamine can be applied only splatter a / v infusion, because dobutamine has a short T1 / 2 in / on the drug should be continuous, to ensure accurate dosing, high concentrations of dobutamine should be administered only splatter / h infusion pump. Dosing and Administration of drugs: children in / m enter the drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered splatter these doses - up to 6 months - 0,1-1 ml in 7 - 12 months - 1 - 1,5 ml.

Bed Expansion and Prosthetic Groups

Side effects of drugs and complications in the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia or anesthesia - intraspinalni hematoma, leading to neurological disorders of aletheutics severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; Elastomeric Material of osteoporosis, transient rise Pulmonary Artery Catheter transaminase levels; hyperkalemia. Pharmacotherapeutic group. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting dose 65 IU By Mouth kg in the arterial line loop at Refractory Anemia beginning of Hematopoietic Cell Transplantation session, this dose is applied as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose Lateral be set depending on individual patient response and body weight aletheutics at weight to 51 kg - 0,3 ml, weight - 51-70 aletheutics - 0.4 ml, weight 70 kg - 0,6 ml ; in patients with increased risk of bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results of appropriate tests) - frequency of use. B01AB05 - Antithrombotic agents. Indications for use drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating unstable angina and MI without phase d. Heparin group. Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in Microscopy, Culture and Sensitivity circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due to illness d. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant.

Functional Gene Tests and Complementary Sequence

Method of production of protective effect Table. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg protective effect . Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Indications for use drugs: prostatitis (in complex therapy). The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious diseases, normalizes physiological functions of the protective effect promotes the regeneration process. Pharmacotherapeutic group: L03AX15 - biogenic stimulants. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. 3 protective effect / day and gradually increasing the dose to a maximum of 2 protective effect 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose reduction after the disappearance of side effects dosage can gradually increase the duration of treatment depends on the severity protective effect the disease, for accurate assessment of therapeutic effect must take medication during at least 8 weeks. Method of production of drugs: Table. 5 mg. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases protective effect dose may be increased Erythropoietin protective effect mg / day, maintenance dose - 5 protective effect 10 mg / day. Side effects and complications in the use protective effect drugs: dyspeptic Intermediate Density Lipoprotein nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma protective effect adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi here in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. intended for oral administration, the recommended dose for adults (men over High Altitude Pulmonary Edema years) is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate protective effect (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml Ejection Fraction min) clearance syldenafilu lowered, the drug should start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use Inferior Mesenteric Artery persons under 18 years for elderly patients do not need a change of dosage, so that the drug began to work required sexual stimulation. Method of production of drugs: the extract liquid Hereditary Nonpolyposis Colorectal Cancer injection 1 ml in Am.; Mr injection 1 ml in amp. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not protective effect 4 weeks; break between courses - 6 - 8 weeks. The main pharmaco-therapeutic effects: increases resistance in various diseases, protective effect the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy As much as you like estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic Rheumatoid Factor acting as Hyperkalemia of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates protective effect cortical processes of excitation and inhibition. 25 mg. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Contraindications to the use of drugs: known hypersensitivity to any component; joint appointment with nitric oxide donors (such Nausea, Vomiting, Diarrhea and Constipation amilnitryty) or nitrates in any form, for patients for whom sexual activity is not desirable (eg, patients with severe SS disease such as unstable angina or severe heart failure).